bladder cancer
Arquer Dx Developing Urine-Based Protein Biomarker Tests to Detect Bladder, Endometrial Cancers
Premium
Arquer's assays use mouse monoclonal antibodies to detect levels of MCM5 proteins in cells exfoliated into urine to detect either bladder or endometrial cancers.
European Consortium Nets €1M for Test to Predict Bladder Cancer Immunotherapy Response
The Eurostars grant will allow PamGene, Novigenix, and Radboud University Medical Center to develop a liquid biopsy test using mRNA and kinase activity profiling.
University of Birmingham, Nonacus to Develop Urine Cancer Liquid Biopsy Assay
The partners plan to offer the assay, which uses Nonacus' liquid biopsy sample prep platform and a biomarker panel validated by the university, by mid-2022.
Researchers Find Keratin 17 Biomarker Shows Promise as Diagnostic Indicator for Bladder Cancer
Premium
The biomarker can detect both aggressive and low-grade forms of bladder cancer, and a test for the biomarker has been licensed by KDx Diagnostics.
A new publication detailing ctDNA testing results has spurred a minimal residual disease biomarker-directed trial for Roche's atezolizumab in bladder cancer.